Sema4 Company

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

Estimated Revenue: $50M to $100M
Funding Status: IPO
Headquarters: Stamford, Connecticut, United States
Total Funding: 791000000.0
Last Funding Date: 2022-01-18
Investors Number: 17.0
Founded Date: 2017-01-01
Technology: Сancer Diagnostics
Industry: Data Processing
Last Funding Type: Post-IPO Equity
Employee Number: 501-1000